Delic Corp

Name

Delic Corp

Legal name

Delic Holdings Corp

Website

https://deliccorp.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

1–10 employees

Short description

Delic Corp is a publicly traded psychedelic wellness company operating the largest ketamine treatment clinic chain in the United States, serving individual patients through 12 operational clinics with 15 more in development.

Ownership category

akta.pro rank

Product category

Ketamine Wellness Clinics

NAICS

Outpatient Mental Health and Substance Abuse Centers (621420)

SIC

Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Substance Use Detoxification Centers (Medical Detox) (HLAFACAD)

Keywords

• Ketamine wellness clinics
• Psychedelic medicine
• Mental health services
• Wellness treatments
• Clinic-based therapy

Headquarters

HQ city

Mesa

HQ country

United States

HQ region

North America

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Psychedelic wellness clinic services: Delic generates revenue through its network of ketamine wellness clinics providing psychedelic treatments to patients across the United States.

Go-to-market motion1 record

Distribution channels1 record

Core offering

Delic Corp operates a chain of ketamine wellness clinics (Ketamine Wellness Centers) that administer ketamine infusion treatments to individual patients seeking psychedelic-assisted mental health and wellness therapies. The company also operates a media platform covering psychedelic wellness content, supporting patient education and brand awareness across its clinical service line.

Differentiator

Problem solved

Functional benefit

Products and services

• Ketamine Wellness Centers (KWC) A network of ketamine wellness clinics that administer ketamine infusion treatments to individual patients seeking psychedelic-assisted mental health and wellness therapies. The clinics serve adult patients seeking treatment for conditions such as treatment-resistant depression, anxiety, PTSD, and chronic pain. Delic operates 12 clinic locations with 15 additional clinics in development.
• Delic Media Platform A media platform covering psychedelic wellness topics, serving as a consumer-facing content channel supporting patient education, brand awareness, and patient acquisition for Delic's clinic services.

Quantifiable outcome

• Expanded network to 12 locations serving millions of patients

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Ketamine Wellness Centers Inc (KWC)coreStrategic or Co-development Partner · 9 November 2021Delic completed the acquisition of Ketamine Wellness Centers Inc (KWC), establishing itself as the largest psychedelic wellness chain in the United States. The acquisition added 10 operating clinics with plans for 15 more in development, significantly expanding Delic's footprint in the psychedelic medicine sector.

Scale indicators3 records

Emerging players

• GH Research: Clinical-stage company developing 5-MeO-DMT therapies for treatment-resistant depression. Adjacent psychedelic treatment developer serving a similar specialty mental-health patient base.
• Wave Neuroscience: Operates ketamine treatment clinics alongside other neuro-treatment modalities. Comparable emerging player in the outpatient ketamine therapy category with overlapping clinical approach.

Direct peers

• Compass Pathways: Clinical-stage psychedelic therapy company developing psilocybin treatment for depression. Operates in the same psychedelic wellness category as Delic, with an overlapping patient base seeking clinic-administered psychedelic therapies.
• MindMed: Public psychedelic medicine company developing LSD and MDMA-based therapies. Targets the same clinical psychedelic treatment market as Delic and is similarly listed on a North American public exchange.
• atai Life Sciences: Clinical-stage biopharmaceutical company developing psychedelic and non-psychedelic treatments for mental health. Comparable to Delic in psychedelic treatment development and clinic-administration strategy.
• Cybin: Public psychedelic therapeutics company developing psilocybin-based and deuterated psychedelic treatments. Targets overlapping patient populations and shares Delic's public-company, psychedelic-wellness positioning.
• Field Trip Health: Was a direct competitor operating ketamine-assisted therapy clinics across North America with a similar media-plus-clinic model. Its discontinuation highlights the operational and capital risks facing clinic-based psychedelic operators like Delic.
• Novamind: Operated outpatient mental-health and ketamine clinics and was acquired by Valar Labs. Most direct operating model comparison to Delic's clinic-based psychedelic wellness network.
• Better U: Operates ketamine infusion clinics in select US markets. A direct single-specialty competitor in the same ketamine-wellness clinic category as Delic.

Broad incumbents

• Janssen Pharmaceuticals (Spravato): Markets Spravato (esketamine), the only FDA-approved ketamine-derived therapy for treatment-resistant depression. Represents the large-pharma incumbent in the same therapeutic category Delic addresses off-label.

Market position

Customer concentration

• Xx.com/deliccorp
• Facebookfacebook.com/deliccorp
• LinkedInlinkedin.com/company/delic-corp

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries1 record

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Delic Corp